HSBC AKT.ANL. 06/25 EVT/ DE000HS4KZP6 /
2024-09-26 9:40:02 AM | Chg.+2.350 | Bid9:45:47 AM | Ask9:45:47 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
54.790EUR | +4.48% | 54.600 Bid Size: 50,000 |
54.750 Ask Size: 50,000 |
EVOTEC SE INH O.N. | 14.00 EUR | 2025-06-27 | Call |
GlobeNewswire
2023-12-11
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune c...
GlobeNewswire
2023-11-07
Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline
GlobeNewswire
2018-02-15
EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
GlobeNewswire
2018-01-08
APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
GlobeNewswire
2017-09-14
MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO
GlobeNewswire
2011-11-29
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
2011-10-27
Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi
GlobeNewswire
2011-09-09
Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...
GlobeNewswire
2011-09-05
Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease
GlobeNewswire
2011-09-05
Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...
GlobeNewswire
2011-08-18
Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...
GlobeNewswire
2011-08-11
Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised
GlobeNewswire
2011-08-11
Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company
GlobeNewswire
2011-07-07
Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases